Neurodegenerative diseases share a number of common pathologies, including neuroinflammation, and so a ligand which targets mGlu5 on inflammatory cells, such as astrocytes and microglia, could have a therapeutic benefit across neurodegenerative diseases. The gene discussed is GRM5; the disease is neurodegenerative disease.